Teva Pharmaceutical Finance Netherlands III BV

CUSIP: 88167AAP6 Class: Corporate Bond - Foreign US$

Holders for Q4 2025 Position Changes for Q4 2025

Note: Option positions (PUT/CALL) are excluded.

Increased Positions (1)

Pacer Advisors, Inc.
Value ($000) $35 (+25.4%) Shares 35,000 (+25.0%)